E-cigarettes

Debate between Kevin Barron and Norman Lamb

Thursday 31st October 2019 Westminster Hall

[Norman Lamb]

I totally agree. The statistics that I am citing make the point about raising awareness, even among clinicians. We thought that it was just the general public who needed to understand better the relative risks, but clearly clinicians also need to understand the relative risks so that they can advise their patients more effectively.

Two in five clinicians feel uncomfortable recommending e-cigarettes to their patients who smoke. Again, that is an extraordinary finding. Fewer than three in 10 agree that their current knowledge is enough for advising patients about e-cigarettes. That extraordinary data reveals a clear need for the awareness raising to which the hon. Member for Dartford (Gareth Johnson) has just referred.

What assessment has the Minister made of the number of smoking cessation services in the NHS that are actively promoting e-cigarettes as alternatives to conventional cigarettes? It ought to be every single one throughout the country, but are they actually doing it? Do we know? Can the Minister tell us what work the Government are doing with NHS England on increasing knowledge among clinicians of the uses, benefits and risks of e-cigarettes for current smokers?

Our report recommended that NHS England should create a post for someone who is responsible for implementing the Government’s tobacco control plan. The response said:

“The Government broadly accepts this recommendation.”

However, no specific steps to implement our recommendation were set out. We pursued that with NHS England, which in January told me:

“It is our intention to appoint an individual with lead responsibility for this role. This will be an important part of our delivery programme for the NHS Long Term Plan.”

We would all assume that that person was appointed long ago and that active work is now underway to pursue this vital agenda, which will save lives, but can the Minister confirm that NHS England has created that post and, if so, is someone actually in post and doing the job?

The Government say that, in their long-term plan, provision is made for

“all smokers who are admitted to hospital being offered support to stop smoking”.

That is not due to be fully implemented until 2023-24. Again, given the extraordinary health benefits of stopping people smoking, I would have hoped for a tighter timescale than ’23-24 to implement that. Will the Minister tell us how implementation of that proposal is going and whether consideration is being given to implementing it fully before 2023-24?

Our report recommended that the NHS should have a clear policy on e-cigarettes in mental health facilities that establishes a default of allowing e-cigarette use by patients. This comes back to my point that approximately 40% of those with severe and enduring mental ill health still smoke. The attitude and culture within mental health trusts is critical if we are to enable and help people with severe and enduring mental ill health to give up smoking. We said that it should be the default that e-cigarettes should be made available in mental health facilities unless there are clear evidence-based reasons for not doing so.

The Government response said:

“NHS England will provide guidance to mental health trusts that sets out that existing vapers should be permitted to use e-cigarettes as part of smoking cessation programmes, and…tobacco smokers should be supported to stop smoking through smoking cessation programmes”.

Can the Minister tell us whether that guidance has been issued? I very much hope that it has. If not, when will it be issued and what is the reason for the delay in issuing such important guidance? If it has been issued, what assessment has been made of how it is working?

The UK is making good progress in getting people to stop smoking and use e-cigarettes to achieve that, but that is at risk from recent concerns about e-cigarette use. Those concerns have been expressed particularly in other countries. We have put the concerns to Public Health England. The first is the claim that deaths in the US have been linked to the use of e-cigarettes and vaping products. The reality is that the US operates in a totally different regulatory context and “illicit products” were

“implicated in this outbreak…including vaping cannabis derivatives.”

That is from Public Health England. It has also explained that

“the suddenness of the outbreak across many USA states in just a few months, suggests that this is not a gradual effect of long-term use, but because of a specific agent coming into use in the affected population.”

Next are the concerns that flavoured e-cigarettes are “luring” children into vaping. Public Health England’s response explained that the data it had seen so far was reassuring that e-cigarettes were not re-normalising smoking. Furthermore, the UK and the US have different rules on advertising, nicotine concentration and education on vaping, which explains why flavours of e-cigarettes are less impactful in the UK compared with the United States.

The next issue is the introduction of a ban in India on the production, import and sale of e-cigarettes because of concerns about the risks that they pose to health and to the young. Again, an assertion has been made that is at risk of infecting the debate that we have in this country. However, Public Health England has explained:

“India is one of several countries that appears to be responding to the outbreak of lung disease among cannabis”

vapers

“by proposing a ban on nicotine inhalers.”

It has also explained that smoking is far more prevalent in India and causes 7 million deaths a year there.

[Sir Kevin Barron (Rother Valley) (Lab)]

Is it not true that India has a massive vested public interest in the tobacco industry?

[Norman Lamb]

I suspect that the right hon. Gentleman knows better than I do, but I note the point that he makes. My view, based on the evidence that the Committee heard, is that the action taken by India is not based on evidence and is likely to result in more people dying of lung cancer. I think that is shameful.

I encourage all right hon. and hon. Members to read the helpful and comprehensive reply that we received from Public Health England on these issues and others, and which we have published so that anyone can delve into the detail. I am reassured that Public Health England is in “close dialogue” with a range of international partners, and I agree with Public Health England when it says:

“It is no exaggeration to say that inflating fears about e-cigarettes could cost lives.”

Incidentally, I have concerns about the attitude at the World Health Organisation, which does not take the same evidence-based approach, as far as I can see, as this country has done. Again, that has implications through the potential loss of life for millions of people across the globe.

It seems to me that people often conflate the fact that we do not have all the long-term evidence on vaping impact with an assertion that that should lead us to conclude that we should not be recommending vaping as an alternative to smoking. Frankly, that is stupid as a public policy approach, because we know that smoking is killing—I think—more than 70,000 people in England every year, and all the evidence so far shows that nothing like that is happening from vaping. According to Public Health England, it is 95% less dangerous than smoking. Therefore, the clear public health advice has to be that vaping is an appropriate way to help people give up smoking. Of course, the best thing of all is not to vape and not to smoke, but if that is not possible for someone, the clear public health advice needs to be that vaping is better than smoking.

Will the Minister set out what contact the Government —she or other Ministers—have had with other countries on international approaches to e-cigarettes? In particular, what are they doing at the World Health Organisation to encourage a more enlightened approach? What assessment have the Government made of the effects of those international approaches on public perception of e-cigarettes in the UK? What steps will the Minister take to ensure that this misinformation on e-cigarettes is challenged?

Tobacco Control Plan

Debate between Kevin Barron and Norman Lamb

Thursday 13th October 2016 Westminster Hall

[Norman Lamb (North Norfolk) (LD)]

It is a pleasure to serve under your chairmanship, Mr Brady, and to follow the hon. Member for Harrow East (Bob Blackman). I find myself in agreement with everything he said. Anyone who has come here hoping to see violent disagreement and robust debate will be disappointed, because we all agree about the importance of this issue.

The hon. Gentleman talked clearly about the nature of this lethal product, which, as we have heard, kills 96,000 people a year across the UK. He also touched on the issue of the developing world. It is anticipated that 8 million people across our world will die from smoking in 2030, and that 80% of them will be in low or middle-income countries that do not have strategies to tackle the problem. Companies based in this country are selling this lethal product to the developing world and killing so many people. We need to be clear that that is shameful.

Many hon. Members, including the hon. Member for Totnes (Dr Wollaston) and the hon. Member for Stockton North (Alex Cunningham)—I congratulate him on all the work he has done and on leading this debate—have talked about the inequalities that are associated with smoking tobacco, including wealth and income inequalities. Smoking hits people from low-income communities much harder than others. As Members have said, smoking is about half of the reason for the difference in life expectancy between the richest and the poorest in our country.

I want to talk about another inequality, which the hon. Member for Harrow East touched on at the end of his contribution: the impact on people with mental ill health. A substantial part of the reason why such people, particularly those with severe and enduring mental ill health, die 15 to 20 years earlier than others is higher smoking rates. Here’s the thing: we have been very successful in this country—I will come back to this in a moment—at reducing the smoking rate. Public health strategies have worked effectively, although we all recognise that there is much further to go. But as the smoking rate has come down in the population as a whole, it has remained stubbornly high among those with severe and enduring mental ill health; there has been hardly any shift at all. That has been a failure of public health strategies.

Back in 2013, when the smoking rate across the population was 21%, it was 40% among those with severe and enduring mental ill health, 60% among those with psychosis, and 70% among people in in-patient care. We can start to see why those people end up dying so much earlier than everyone else. That amounts to a neglect of those people’s need for support in combating this highly addictive product, and it makes me absolutely driven—as is everyone else in the Chamber—to do more to combat the problem.

Let me come back to the successes of smoking cessation strategies. I join other hon. Members in congratulating the hon. Member for Battersea (Jane Ellison) on her work. The hon. Member for Harrow East was right; there are Government Members who take a different view. I remember hearing the hon. Member for Battersea speaking and wanting to tell her to watch her back, because there were quite a few Members behind her who took a different view. She was brave in standing her ground, particularly in pursuing the plain packaging policy. The right hon. Member for Rother Valley (Kevin Barron) has a plain packet in his pocket. The previous Government were in my view a coalition Government, not a Conservative-led Government; the Liberal Democrats played our part in important strategies such as plain packaging and ending smoking in cars with children on board, which will have a big impact on saving people’s lives.

It is imperative that the new strategy is published and becomes operational. Given the leadership role that we have played for so many years, it is important that we go to the meeting in India in November and demonstrate our continued leadership. If there is any way for the strategy to be published before that meeting, and for it to include a focus on how we will use the fund that has been established for combating smoking in developing countries, I urge the Minister to do everything possible to ensure that that happens.

Let me speak a little more about what the tobacco control plan needs to include. I come back to what I said about mental health, which the plan needs to address directly. I do not know whether the Minister has seen the iterations of the plan, which we hope will be published soon, but I hope very much that it will address directly the failure of public health strategies to reduce smoking among people with mental ill health. The plan needs to focus on the recommendations of the report “The Stolen Years”, which was published by ASH and produced in collaboration with the Royal College of Psychiatrists, and its ambitious targets for reducing smoking among people with mental ill health. We can no longer fail to confront the failure of past strategies in that respect. Interestingly, that report highlights the therapeutic benefits of stopping smoking for people with mental ill health, not only for their physical health but for their mental health. Ironically, many people with mental ill health smoke because they see it as an escape from the pain that they are suffering and a way of coping with stress, yet smoking increases stress and the risk of aggression, particularly in in-patient services.

[Kevin Barron]

I went to the launch of that report. Some 70% of people who are discharged from mental health secure units smoke, yet we have in our midst a product—e-cigarettes—that could have been designed to be put into such institutions, some of which are now putting e-cigarettes on their shopping lists. That would allow people to satisfy their addiction without creating secondary smoke and the many ailments that occur when people smoke. Does the right hon. Gentleman agree that we need more leadership to ensure that e-cigarettes can be used in institutions where, for control reasons, it is difficult to keep the customer satisfied, as it were?

[Norman Lamb]

I completely agree. If we want to focus effort where it is most needed and where smoking rates are highest, we should focus on those very mental health institutions. As well as making vaping available for people who need help to give up smoking, we need to do much more to focus on training staff in such institutions so that they know the importance of smoking cessation being one of the objectives in the care of individuals there, because of its potential therapeutic benefit.

I should also mention the move towards smoke-free in-patient settings, a strategy that I supported as Minister and that I am pleased is continuing. Guidance was published by Public Health England and NHS England in June 2015, and that strategy is having a beneficial effect on the environment in in-patient settings by reducing aggression and stress and improving physical and mental health. I encourage the Government to keep pursuing that objective.

On electronic cigarettes and vaping, although I was a committed remainer in the EU referendum debate, the tobacco products directive is flawed, because it takes an inappropriately tough approach to electronic cigarettes. I therefore hope that the Government will review that directive regularly. One of the potential benefits of leaving the EU—there are not many, in my view—is that we will gain the ability to differentiate more between the effective regulation on tobacco in that directive and the regulation on electronic cigarettes, and do much more to recognise the evidence that already exists, as the right hon. Gentleman has made clear, on the benefits of electronic cigarettes.

I will end by saying something about public health funding. The hon. Member for Totnes made the point clearly, and I totally share her view. The Health Committee has pointed out that the £8 billion or £10 billion that we keep being told will be given to the NHS by 2020 is actually nearer £4.5 billion. Extra money is being found for front-line NHS services partly by cutting other parts of the Department of Health budget, including, distressingly, public health and health education. As she said, that is completely counterproductive. When NHS finances get tight, crisis management takes over. The hon. Member for Stockton North made the point that CCGs are focusing on propping up established traditional services—the repair services, as it were—and in so doing, tragically, are cutting the prevention services that prevent people from ending up needing care in the first place. That is so counterproductive. A new settlement for the NHS and the care system, which I keep calling for, must recognise the imperative to invest more in prevention and public health, particularly given that there is so much evidence that that has a beneficial effect.

Tobacco Control Strategy

Debate between Kevin Barron and Norman Lamb

Thursday 17th December 2015 Westminster Hall

[Kevin Barron (Rother Valley) (Lab)]

I beg to move,

That this House has considered a new tobacco control strategy.

I am pleased to speak in this debate with you in the Chair, Mr Betts, because we are not talking about football today—our teams are doing different things in the league at the moment. I ought to declare that I am the vice-chair of the all-party group on smoking and health, and have been an officer of sorts for it for some 20 years. I am sure Members are aware that the group’s secretariat has been the Action on Smoking and Health charity for many years.

My commitment to tobacco control is well known in this House. For the more than 20 years that I have been involved in this issue, I have had great support from Action on Smoking and Health, as I know Governments have from time to time. My commitment was an individual one at one stage, going back a couple of decades, so I am pleased that in recent years we have seen a growth in cross-party support for tobacco control, as people recognise that it is a key area of public health.

The Minister has played a key leadership role in guiding through the House measures such as standard packaging and the prohibition on smoking in cars with children. She has been helped by the strong support for these measures across Parliament, both here and in the other place. We have moved on in leaps and bounds on this major public health issue in the past decade. Measures to tackle the harm caused by smoking are strongly supported by the public, three quarters of whom supported Government action to limit smoking in a YouGov poll conducted for ASH, and around half of whom think the Government could do more.

In recent years, a great deal has been achieved with the support of the public and all political parties, starting with the Labour Government introducing the first comprehensive tobacco control strategy in 1998; they subsequently introduced comprehensive smoke-free legislation with strong cross-party support. The coalition Government published as their first detailed public health strategy the tobacco control plan for England in 2011. Over the life of the current plan, a great deal has been achieved, and smoking prevalence rates in England have fallen significantly during the five years of the plan from some 20.2% in 2011 to 18% in 2014.

[Norman Lamb (North Norfolk) (LD)]

I am not sure whether the right hon. Gentleman will cover this, but I am particularly interested in smoking prevalence rates among those who suffer severe and enduring mental ill health. It appears to have been stubbornly more difficult to reduce smoking rates among that group. Given that people with mental ill health die earlier, and that smoking actually damages their mental health, does he agree that it is critical that the NHS ensures that those people get access to support services to help them give up smoking?

[Kevin Barron]

The right hon. Gentleman is absolutely right; there is a high incidence of smoking among people with mental health conditions, as there is among poorer households. I will go into that in more detail, but he is right to mention it.

Smoking rates have fallen among not only adults but, importantly, young people. Regular smoking among 15-year-olds has fallen even faster under the plan, from 11% in 2011 to just 6% in 2014. That is a great credit to the current plan, but it is about to come to an end, so we need a new strategy.

The reduction ambitions set out in the tobacco control plan for England have been achieved ahead of the end of the strategy. However, a great deal remains to be done. Smoking remains by far the single largest cause of preventable illness and premature deaths in the United Kingdom, causing about 100,000 premature deaths a year and killing more people than the next six causes put together, including obesity, alcohol and illegal drugs. The cost of smoking to the national health service in England is estimated to be about £2 billion a year.

My constituency, Rother Valley, sits in Rotherham borough. Just under one in five people smoke in Rotherham, which is about the same as the national average. That amounts to some 37,391 people. Nearly 500 people in Rotherham die from smoke-related diseases every year—primarily cancer, heart disease and respiratory diseases. An estimated 900 children in Rotherham start smoking every year, and it is important to remember that two thirds of smokers start before the age of 18. Of those who try smoking, between one third and one half will become regular smokers. The best way to prevent children taking up smoking is to encourage their parents to quit, because children are three times more likely to start smoking if their parents smoke.

Smoking rates are much higher among poor people. In 2014, 12% of adults in managerial and professional occupations smoked, compared with some 28% in routine and manual occupations. Almost all groups that experience disadvantage have higher smoking rates than the general population. For example, as the right hon. Member for North Norfolk (Norman Lamb) mentioned, people with mental health conditions are much more likely to smoke, and nearly eight out of 10 prisoners and people who are homeless smoke.

Poorer smokers also face financial hardship as a result of smoking. When their expenditure on smoking is taken into account, some 1.4 million households are below the poverty line—that is 27% of all households that include a smoker. In Rotherham alone, smoking is estimated to cost the national health service some £12.2 million. The current and ex-smokers who require social care in later life as a result of smoking-related diseases cost society in Rotherham an additional £5.7 million, £3.3 million of which is funded by the local authority through social care costs, and £2.4 million of which is self-funded.

Quitting smoking surveys show that about two thirds of smokers would like to stop smoking, but only around one third make a quit attempt in any given year. Continued Government and public sector action to cut smoking rates therefore remains necessary, and a new strategy is required to replace the expiring tobacco control plan.

The current Department of Health tobacco control plan will expire at the end of this month, as I understand it. I am delighted that the Minister with responsibility for public health has announced that there will be a new plan, and I look forward to her announcing when it will be published; we may hear something today. It is crucial that a new tobacco control plan be a public health priority, and it has to be comprehensive. The current strategy has been successful because it is comprehensive and, so far, properly funded.

The main elements of successful tobacco control, as implemented in the UK, are well understood and strongly backed by evidence. They are: price rises through taxation, intended to make tobacco less affordable and to help pay for tobacco control interventions; stopping the smuggling of tobacco, which allows children and young people easy access and reduces the incentives for adult smokers to quit; helping smokers to quit through evidence-based services, including support and, where appropriate, the prescription of nicotine replacement products; an end to tobacco advertising, marketing and promotion, including on the pack design; and mass-media campaigns and social marketing of anti-smoking messages. Legislating for smoke-free enclosed public places and vehicles to protect people from the harmful effects of second-hand smoke has been a great success. The new strategy will need to be comprehensive and ambitious, with tough new targets, and it has to be well funded.

I commend to the Minister the comprehensive set of measures set out in the ASH document, “Smoking Still Kills”, which has been endorsed by more than 120 public health-related organisations, including the British Heart Foundation, Cancer Research UK, medical royal colleges and the British Medical Association. The report calls on the Government to impose an annual levy on tobacco companies, proposes new targets for reducing smoking prevalence to make our country effectively tobacco-free by 2035, and makes a comprehensive set of recommendations for a renewed national strategy to accelerate the decline in smoking prevalence over the next decade.

Hon. Members will remember that at the launch of that report in June, the Minister committed the Government to publishing a new strategy to replace the current plan. Sustained funding is essential to the success of any new strategy, as it has been for Government strategies to date. Clear evidence from the UK and overseas shows that a reduction in spending on tobacco control, together with less emphasis on new policies and on enforcement of existing ones, is likely to slow, halt or even reverse the long-term reduction in the smoking prevalence rate.

Some measures, once implemented, either do not need funding—such as standardised packaging, and the ban on advertising, promotion and sponsorship—or are self-funded, such as tax increases and reductions in smuggling. Others continue to need to be properly funded, including mass-media campaigns, stop smoking services and enforcement to prevent children from being able to buy cigarettes.

I am deeply concerned that the cuts in funding to the Department of Health and local authority public health budgets, both in-year and announced in the spending review, threaten to undermine the ability of the planned new tobacco control plan for England, so that, unlike the current plan, it will not be effective. We are already seeing cuts to stop smoking services up and down the country, and to local authority investment in tobacco control, even before the spending review cuts are implemented. Will the Minister confirm that the new tobacco control plan will contain ambitious targets and be sustainably funded?

I want to focus on the importance of mass-media campaigns, which are highly cost-effective in encouraging smokers to quit and in discouraging young people from taking up smoking. When funding was cut to mass-media campaigning in 2010, when the coalition Government came in, there was a noticeable impact on quitting behaviour. There was a decrease of 98% in the amount of quit support packs. Quitline calls fell by 65% and hits on the website fell by 34%, but the evidence shows that such services are only effective if they are sufficiently well funded; in recent years, they have not been.

At the peak in 2009-10, nearly £25 million was spent by the Government on mass-media campaigns. However, last year, in monetary terms, not taking inflation into account, the amount had fallen to less than £7 million, and it is likely to fall again this year. Investment in mass-media campaigns is a crucial part of the mix of tobacco control interventions needed to drive down smoking rates, and the UK is seriously under-investing.

To give an international comparison, in the US, the Centres for Disease Control and Prevention’s best-practice recommendations for mass-reach health communications to reduce smoking is $1.69 per capita. Using 2014 population figures, that means that in England, we should be spending in the region of £57 million a year on mass-media campaigns for that to be evidence-based. We are spending eight times less than that.

The cut in spending is already having an impact. An early indicator of the effects of reductions in spending on tobacco control is given by the smoking toolkit study run by Professor Robert West, from University College London. Results for 2015 show that smoking prevalence has stopped declining and is beginning to go back up again for the first time in many years.

Smoking rates have increased from 18.5%—the lowest ever recorded—to 18.7% in recent months. There has also been a fall in the proportion of smokers who made an attempt to quit, from 37.3% in 2014 to 32.4% in 2015. There are lower success rates for quit attempts, from 19.1% in 2014 to 17.0% in 2015. That is going in the opposite way to how it should be going.

I want to move on to an area on which the public have contrasting views: the role of electronic cigarettes, which are perhaps badly named, and harm reduction. Over the last few decades, it has become increasingly clear that although population smoking rates had been declining, some groups—particularly the poor, the disadvantaged and those with mental health problems—were being left behind. Those are the groups with the highest levels of nicotine addiction, who find it hardest to quit.

At present, the most popular source of nicotine—the cigarette—is far and away the most hazardous and addictive. In response to that, tobacco harm reduction approaches have been developed in the UK to find ways of giving smokers who are unable to quit access to alternative, less harmful forms of nicotine. We are at the forefront in the world in developing such an approach. Current smoking cessation programmes use nicotine replacement therapy, but they also use non-nicotine approaches such as psychotherapy and other pharmaceutical products. Although there has clearly been success with those products, they predate the advent of electronic cigarettes as a major consumer product.

Electronic cigarettes are now widely on sale and have become the most popular tool used by smokers to help them quit. There is growing evidence that they are effective aids to quitting, and they are used by around 2.6 million smokers, primarily to help them quit or prevent them from relapsing back into smoking. Although concerns have been raised about their use by young people and never-smokers, this has not been found to be an issue. Indeed, use by adults who have never been regular smokers is very rare, and although a growing number of young people under 18 have experimented with electronic cigarettes, regular use is limited almost exclusively to young people who are current smokers or who have experimented with smoking in the past.

More worryingly, evidence from ASH indicates that the public increasingly have false perceptions of the harm from electronic cigarettes, and smokers who have not yet tried an electronic cigarette are much more likely than other smokers to believe they are as harmful as conventional cigarettes, or more harmful. That is certainly not the case. A recent groundbreaking review by Public Health England, which was published in August, found that they are 95% safer than smoking tobacco and recommended that health providers and stop smoking services take a more proactive approach in supporting smokers who want to use electronic cigarettes to quit smoking.

For 50 years we have known now that it is not the nicotine in cigarettes that does the damage to people, but the contaminants in the tobacco. However, some people, including in the medical field, are talking electronic cigarettes down as though they were as dangerous as cigarettes. That figure of 95% safer gives us 5% wriggle room, because I do not think that has been tested or proven at this stage. It could be far higher than that, but this product is a way of taking nicotine into the system that does not do the damage that tobacco does.

I believe a large part of the delay in the roll-out of electronic cigarettes has been due to the fact that they were not developed in the UK, or not through traditional methods in national health service labs. I just wish they had been, because then some medical practitioners in the NHS would have had a different attitude to them. The regulatory systems are not used to this sort of organic growth that comes in from outside. However, the Medicines and Healthcare Products Regulatory Agency’s new approach to licensing e-cigarettes is a welcome step. To my knowledge, the MHRA is the only medicines regulator in the world to licence an e-cigarette, as happened earlier this month. They will potentially become a major part of smoking cessation programmes.

Unfortunately, there are high costs to putting e-cigarettes through the MHRA, and from conversations with British suppliers it is clear that the licensing costs are prohibitive for smaller manufacturers if they want them to be a medicinal product. That is obviously a major block, and it is argued that only the tobacco companies are putting those products through the MHRA at the moment. That may be because they have the money to be able to put them through at this stage. I would prefer a tobacco company to spend money on putting these products through the MHRA, so that they can get into smoking cessation clinics, than to sell cigarettes, which prematurely kill 50% of the people who use them. We should take our head out of the sand and look at the potential of these products to get everyone off cigarettes, which are so damaging to their health.

I recently met someone who runs a small business in my constituency and has developed a product called E-Burn, which is an e-cigarette for use in prisons. It is currently used in the prison on Guernsey and is being adopted by the NHS for use in secure hospitals. That innovation is taking place out there. I have not tasted that product and I do not know it from any other, but when I was on the Select Committee on Health in 2005-06 and we did an inquiry on smoking in public places, one of the most difficult things was trying to convince people that those in prisons ought to have smoke-free workplaces as well.

[Norman Lamb]

It should also be mentioned that in mental health settings and in-patient wards, where no-smoking policies have been introduced and patients have been helped to escape from addiction to tobacco, a significant improvement in their mental wellbeing and mental health has been seen.

[Kevin Barron]

The product to which I referred comes from China, I understand, but is assembled in Rother Valley, and the person who runs that company wants to expand his business and create jobs. I want to encourage him on the basis that it creates better health if these products are used both in mental health institutions and in prison.

I mentioned the 2005-06 report. The Health Committee, which I chaired at the time, had great difficulty in convincing people who ran institutions that smoke-free workplaces should be as much for people inside prisons and secure hospitals as for anyone else. Various arguments were put to us at the time. The major issue was not just about taking people off cigarettes; it was about control in prisons. I now see that from 1 January we are banning smoking in all Welsh prisons and selected English prisons, which we could loosely call non-traditional environments. That has taken a long time. We were told when we were doing that inquiry in 2005-06 that the Prison Service would bring things forward within three months of our completing it. It has actually taken 10 years to get to this stage. I suspect that if e-cigarettes, no matter which ones they are, go into those institutions for people who are addicted to nicotine and cannot get off that addiction, it will help us get what some of us were arguing for 10 years ago.

Next year, the UK will implement the electronic cigarette provisions in the tobacco products directive, which will provide a regulatory framework for those products, giving users greater assurance about their safety and quality. However, e-cigarette users have raised concerns that the UK Government’s implementation of those provisions will force products that they use off the market and may cause them to revert to conventional smoking.

I accept entirely that it is essential that the directive be implemented proportionately. As I understand it, the MHRA will be responsible for that, although not for making all e-cigarettes medicinal product, which involves high expense. It will bring in a regime whereby it will look at the quality of e-cigarettes, and quite right too. We want to know, if people are buying e-cigarettes in shops on our high streets or wherever, that what the packet says is what is in the product. People should know exactly what they are using. I agree about that, but I hope the Government will ensure that the regulation of electronic cigarettes is proportionate and maximises the benefits to smokers while minimising the risks.

I want to finish by discussing our role in global tobacco policy. As reported by Public Health England, money has been found in the spending review for the Department of Health to support the international implementation of tobacco control. The UK, as a world leader in tobacco control and in supporting development internationally, has a key role to play in that area. I am pleased to see the Minister nodding. The UK is the first G7 country to meet the long-standing commitment to spend 0.7% of gross national income on official development assistance—a commitment that is enshrined in law, I am very pleased to say as a Member of the House. Building economic growth and creating jobs helps developing countries to lift themselves out of poverty, and we can justly be proud of our work in that area.

Key to effective development work going forward will be helping to deliver on the new sustainable development goals. One of those is to accelerate the implementation of the World Health Organisation framework convention on tobacco control. I hope, therefore, that our new tobacco control plan will be cross-Government and will include an ambitious international strategy to help countries with FCTC implementation.

The Addis Ababa declaration on financing for development, which backs up the sustainable development goals, says that parties, such as the UK, should strengthen implementation of the WHO FCTC and support mechanisms to raise awareness and mobilise resources for the convention. The UK, as a world leader both in development and in tobacco control, has a key role to play in helping to support FCTC implementation, particularly in low and middle-income countries.

The financing for development declaration goes further and states that

“price and tax measures on tobacco can be an effective and important means to reduce tobacco consumption and health-care costs, and represent a revenue stream for financing for development in many countries.”

Clearly the UK has expertise in tobacco taxation: we have some of the highest taxes in the world, combined with a comprehensive and effective strategy to tackle illicit trade. A 2014 study found that tripling tobacco taxes around the world could reduce the number of smokers by 433 million and prevent 200 million premature deaths from lung cancer and other smoking-related diseases. That would benefit UK plc, because increased tobacco taxes of necessity go hand in hand with enhanced anti-smuggling strategies, which we now have to deal with daily. Her Majesty’s Treasury, in collaboration with Her Majesty’s Revenue and Customs, is in the process of setting up a cross-departmental ministerial working group to tackle the illicit trade in tobacco and help HMRC to achieve its aims, which include:

“Creating a hostile global environment for tobacco fraud through intelligence sharing and policy change”.

If other Governments increase tobacco taxes and enhance their anti-smuggling strategies, that will help to create precisely that hostile global environment for tobacco fraud. HMRC is working on that at the moment.

Our international strategy also needs to include work to help countries protect their tobacco control public health policies from the commercial and vested interests of the tobacco industry, and to ensure that UK diplomatic posts do not help tobacco companies promote their deadly products around the world. It was rightly considered a scandal earlier this year when the British high commissioner to Pakistan was revealed to have attended a British American Tobacco meeting with the Government of Pakistan, at which BAT lobbied the Government not to implement tougher health warnings on cigarette packs—a campaign that was successful, sadly. In a recent BBC “Panorama” programme, it was alleged that BAT employees and contractors had been involved in making payments to officials and politicians in Africa in return for access to draft tobacco control legislation. Given the UK’s strong domestic record on tobacco control and our leading international role in promoting successful tobacco control policies, we need to remain vigilant and ensure that we all do everything we can to promote successful tobacco control around the world.

I had personal experience of what the tobacco companies do more than 20 years ago, when I was promoting a private Member’s Bill to ban tobacco advertising and promotion. A lot came out years later through the tobacco files about exactly what had taken place and the influence that those companies exerted to try to stop us doing what this country has now done. They tried to stop us putting this country on the map as a major force in tobacco control, as it is now. Will the Minister confirm that the international work to support the implementation of the WHO FCTC will be a key part of the new tobacco control plan, and that it will include supporting Governments in protecting their public health policies from the commercial and vested interests of the tobacco companies, in line with article 5.3 of the FCTC?

I thank you for your indulgence, Mr Betts—you will be pleased to know that I am about to sit down. The tobacco control strategies have been published, in recent history, about once every five years. They have been crucial to this country in saving the lives of many of our fellow citizens and in our getting a good evidence base for the same thing to happen throughout the world. The last thing I want is for this country to stop doing what it has been doing well. I have asked questions about funding and other things, but there is much that we can do that requires not money but good will and determination.

Oral Answers to Questions

Debate between Kevin Barron and Norman Lamb

Tuesday 24th February 2015 Commons Chamber

[Norman Lamb]

I visited the Haven last week with my hon. Friend, and I was enormously impressed by everything I heard, including the extraordinary testimonies of people with personality disorders who had benefited so much from the Haven’s service. In my view, it would be incredibly sad and very worrying if that service were to be lost. I am happy to invite the clinical commissioning group and the mental health trust to a meeting in the Department to discuss how it can be saved.

[Kevin Barron (Rother Valley) (Lab)]

I recently met the five UK Youth Parliament Members from Rotherham, who talked about the lack of facilities for mental health help in education, both further education and state education. May I say to the Minister that it is all right saying that it is up to local commissioning groups, but where is the leadership, when our young people are being left in extremely difficult situations and are seen by some professionals but, sadly, not health professionals?

[Norman Lamb]

The local Members of the Youth Parliament the right hon. Gentleman met make an incredibly important point. I refer him to the children and young people’s mental health and well-being taskforce, which will report very soon. I think that the role of schools will be crucial in its conclusions, and I encourage him to look at the report when it emerges.

NHS Commissioning Board

Debate between Kevin Barron and Norman Lamb

Tuesday 5th March 2013 Commons Chamber

[Norman Lamb]

We will make absolutely sure that the amended regulations meet faithfully the commitments given in the Upper House during the passage of the Bill, and in the letter sent to clinical commissioning groups by the former Secretary of State following the legislation.

[Mr Kevin Barron (Rother Valley) (Lab)]

During the passage of the Health and Social Care Bill, the Government withdrew clauses that promoted competition and replaced them with clauses that would prevent anti-competitive behaviour. I never understood that at the time. Is it not the case that compulsory competitive tendering is the intention of the regulations and the intention of the original Act?

[Norman Lamb]

The right hon. Gentleman’s own Government had guidance in place precisely to address anti-competitive behaviour. Let me again reiterate that these regulations will not introduce compulsory competitive tendering. The amendments that we will table will make it absolutely clear that the power rests with clinical commissioning groups, and not with the Government, Monitor or anyone else.

NHS Funding

Debate between Kevin Barron and Norman Lamb

Wednesday 12th December 2012 Commons Chamber

[Mr Kevin Barron (Rother Valley) (Lab)]

I am sorry that the Secretary of State is leaving because, before going on to discuss what is happening in my local health community and local hospital, I want to pick up on a couple of the things that have been said. First, I am pleased that this very dry motion has been tabled because I hope that it will concentrate our minds on what is happening in the national health service and, in particular, to spending.

The Secretary of State said that spending is related to budgets. He did not respond to the point posed by my right hon. Friend the Member for Leigh (Andy Burnham) that in 2010-11, there was a £1.9 billion underspend in the national health service budget. No use was made of the budget exchange scheme, so none of that money was moved into the following financial year. We can assume that £1.9 billion went back to the Treasury.

In the following year, 2011-12, the underspend was £1.4 billion, and £316 million was carried over into 2012-13. An underspend in the region of £3 billion from the first two years of this Government—including the year they won the general election—has gone back to the Treasury. Those are the facts; I do not know if any Front Bench Member wishes to dispute them.

[The Minister of State, Department of Health (Norman Lamb)]

Does the right hon. Gentleman also acknowledge that the average underspend in the last four years of the Labour Government was £1.9 billion?

[Mr Barron]

I recognise that there has been underspend, but I take this debate, and the debate we had running up to the general election, a bit more seriously. The chairman of the UK Statistics Authority said that there had been an underspend, and what we have just heard is not true. As my right hon. Friend the Member for Leigh (Andy Burnham) said, the Conservative party manifesto stated:

“We will increase health spending in real terms every year.”

--- Later in debate ---

[Mr Barron]

The issue of allocation has been looked at by many Select Committees, including by the Health Committee when I chaired it in the last Parliament. We did not find the level of unfairness that people, particularly those from rural areas, used to say there was. We looked for it but we did not find it.

Let us look at what is happening in the real world. My local Rotherham hospital foundation trust is not a bad hospital trust in any way and scores quite well in many areas. It received foundation trust status a number of years ago, and when this Government took office, it is fair to say that the efficiency factor was there already. On 16 March 2011 the trust announced that more than 60 jobs were to be axed at Rotherham general hospital, and confirmed a potential reduction of 62 posts in medical and surgical areas. Earlier this year on 6 March 2012, the local BBC announced that more than 70 NHS staff were facing the threat of redundancy, and the trust is seeking to save about £4 million. On 26 October 2012, an internal report given to the local media stated that the trust now intends to cut 750 jobs—about 20% of its work force—by 2015.

The NHS trust said that it needed a smaller hospital with substantially fewer beds and a smaller work force to save £50 million over the next four years. The internal report—aptly named, “Creating Certainty in an Uncertain World”—said that it was necessary to save £50 million from the £220 million budget before 2015 to meet Government targets. That was confirmed by the trust in a press release.

On 5 November 2012, the chief executive of the trust said that it would show staff the plans and invite them to come back with alternative views on how things might be done differently. The trust stated:

“We’ve made it very clear that there may have to be redundancies, but to be honest with you until we have gone through the process, I don’t know how many we will be able to lose through natural turnover and how many will have to be made redundant.”

What type of planning is there in any of this when we have such a situation in a district general hospital on which about 80% of my constituents rely if they have to go into secondary care?

On 20 November 2012, the chief executive announced his retirement. On 3 December 2012, the hospital announced that staff will be informed about the decision to postpone the formal consultation launch into work force restructuring. It went on:

“We realise this an anxious time for all members of staff, but it is imperative that we do what is right for the Trust, our staff and our patients. This means that we need to take more time to ensure our workforce proposal is exactly what the Trust requires and we anticipate the launch to take place later in the month.”

On 7 December 2012—last Friday—a headline in the local newspaper stated that the trust had recently engaged the services of a director of transformation on a time-limited basis. The acting chief executive said:

“It is important that the trust acts quickly to take the action required to safeguard the future clinical and financial sustainability of the Trust. This appointment, which was made after a competitive process, is required to provide additional expertise and impetus to the changes we need to make, whilst allowing others to remain focused on delivering the healthcare services that the people of Rotherham need and deserve.”

I do not stand here and support the way the NHS has been structured now or in the past, and I have been critical about many areas of that. I agree with the chief executive of the NHS, David Nicholson, who said at the NHS confederation conference this year:

“We need to change the model of care to one which supports patients and focuses more on preventing ill health from happening in the first place...and move away from the default position of getting someone into a hospital bed.”

At the same conference the then Health Secretary said that closure decisions were not an issue for national politicians, and my right hon. Friend the Member for Leigh said that the current Health Secretary said very much the same thing—“It’s nothing to do with me, guv.”

Let me say to the Minister, and other hon. Members who have made relevant interventions, that if changes and reconfigurations inside the national health service are getting better care to more patients, that is fine. However, the chaos in my local health service is about cutting back and saving money. I have played an active role in health care in my constituency over many years and, as far as I know, there has been no debate with local Members of Parliament, patients, patient groups, local doctors or people engaged in health provision in Rotherham. There have been no discussions whatever about reconfiguring the district general hospital to improve the position of patients and of the people of Rotherham and the surrounding area. Instead there is a drive to save money, which is creating chaos in my local health service.

[Norman Lamb]

Does that not demonstrate a complete failure at local level to address the real problems that we are trying to grapple with? There is therefore a case for a changed system whereby a health and wellbeing board brings all the parts of the system together to debate such issues.

[Mr Barron]

The events of the past two months suggest to me that the people in whom the Minister has faith to reorganise health care in Rotherham do not know what they are doing. They have brought in new systems and produced a report inside the hospital, which I understand was given to the trade unions. It ended up on the front page of a local newspaper and was countered by a press release by the hospital itself. Where is the debate about improving health care for my constituents and others? It is absent.

I say to the Minister that it was wholly wrong for the previous and current Secretaries of State—he is not the Secretary of State himself, but we never know, he may be one day—to say “These are not matters for Ministers”. I have not been consulted about them. The three local MPs had an appointment with the chief executive of the trust about two weeks ago, but it was cancelled because he had announced his retirement the week before. That is not acceptable.

The hard reality on the ground is that no matter what we would like to happen in health care, trusts are charging into cutting budgets. They are cutting jobs, because that is where the major expenditure is in health care, and that is creating the chaos that I have described. It is not acceptable. My constituents pay their taxes to pay for health care—it does not come out of the budget down here in Westminster—and they deserve better than what they are getting at the moment.